Hepatic Encephalopathy

Hepatic encephalopathy is a reversible neuropsychiatric syndrome that arises when the liver fails to clear nitrogenous and other gut-derived toxins, allowing them to reach the brain. It spans a spectrum from subtle, only-detectable-on-testing changes (covert or minimal encephalopathy) to disorientation, confusion and coma (overt encephalopathy), and is a defining complication of both acute liver failure and cirrhosis.

Definition

Hepatic encephalopathy is a potentially reversible disturbance of brain function caused by liver insufficiency and/or portosystemic shunting, producing a spectrum of neurological and psychiatric abnormalities ranging from minimal cognitive changes to coma.

Scope

The entry covers the definition and grading of hepatic encephalopathy, its classification by underlying liver condition (types A, B and C) and by time course, the central role of ammonia and astrocyte dysfunction in its pathophysiology, and the typical precipitating factors. It is a reference description of the syndrome and not a guide to its management in any individual.

Core questions

• How is hepatic encephalopathy classified and graded?
• What is the role of ammonia and astrocyte swelling in its pathophysiology?
• What factors commonly precipitate an episode in a patient with cirrhosis?
• How does covert (minimal) encephalopathy differ from overt encephalopathy?

Key concepts

• Covert (minimal) versus overt encephalopathy
• West Haven grading
• Type A, B and C classification
• Hyperammonemia
• Astrocyte swelling and cerebral edema
• Portosystemic shunting
• Precipitating factors
• Asterixis

Key theories

Ammonia-glutamine osmotic (astrocyte swelling) hypothesis

Ammonia that escapes hepatic detoxification is taken up by brain astrocytes, which convert it to glutamine; the resulting osmotic load causes astrocyte swelling and low-grade cerebral edema, contributing to the neurological dysfunction of hepatic encephalopathy alongside neuroinflammation and altered neurotransmission.

Mechanisms

Hepatic encephalopathy develops when gut-derived ammonia and other toxins bypass or overwhelm hepatic detoxification and reach the brain. Astrocytes take up ammonia and detoxify it to glutamine; the osmotic effect of accumulated glutamine causes astrocyte swelling and low-grade cerebral edema, which together with neuroinflammation, oxidative stress and altered neurotransmission produce the clinical syndrome (Braissant et al., 2013; Prakash & Mullen, 2010). In cirrhosis, episodes are frequently triggered by identifiable precipitants such as infection, gastrointestinal bleeding, electrolyte disturbance, constipation or certain medications, whereas in acute liver failure encephalopathy reflects severe, rapid loss of hepatic function and carries a risk of dangerous brain edema (Vilstrup et al., 2014; Montagnese et al., 2022).

Clinical relevance

Hepatic encephalopathy is a major cause of morbidity and hospitalization in liver disease and an important prognostic marker, particularly in acute liver failure where it defines disease severity. Recognizing the syndrome and its spectrum is central to hepatology. This entry describes the condition for reference and educational purposes and does not provide diagnostic criteria or treatment guidance for individual patients.

Epidemiology

Overt hepatic encephalopathy occurs in a substantial proportion of people with cirrhosis over the course of their disease, and covert (minimal) encephalopathy, detectable only on specialized testing, is more common still. Its development marks a transition to more advanced, decompensated liver disease and is associated with reduced survival (Vilstrup et al., 2014; Montagnese et al., 2022).

Evidence & guidelines

Hepatic encephalopathy is the subject of joint and regional society guidelines, including the AASLD-EASL 2014 practice guideline (Vilstrup et al., 2014) and the EASL clinical practice guidelines (Montagnese et al., 2022), which standardize its definition, classification and grading. Mechanistic and clinical reviews complement these (Prakash & Mullen, 2010; Khungar & Poordad, 2012).

History

The link between liver disease, nitrogen metabolism and disturbed brain function was recognized in the mid-twentieth century, when portosystemic shunting and dietary protein were tied to encephalopathy. The West Haven criteria later provided a clinical grading scale, and the AASLD-EASL and EASL guidelines consolidated a unified classification by underlying type, severity and time course.

Debates

How central is ammonia, and how useful is measuring it?

While ammonia is the best-characterized toxin in hepatic encephalopathy, blood ammonia levels correlate only loosely with clinical grade in chronic disease, and neuroinflammation and other factors clearly contribute; the value of routine ammonia measurement for diagnosis or grading remains debated.

Seminal works

• vilstrup-2014
• montagnese-2022
• prakash-2010

Frequently asked questions

Is hepatic encephalopathy reversible?

Episodes are typically reversible when the underlying liver problem and any precipitating factor are addressed, although it tends to recur in advanced liver disease and marks a more serious stage of illness.

What is minimal or covert hepatic encephalopathy?

It is a subtle form with no obvious clinical signs that is detectable only with psychometric or neurophysiological testing; it can still affect attention and everyday function and may precede overt episodes.